1
|
Sigurdson S, Biagi J, Langley H, Kennedy K, Mahmud A. Integration of Ongoing Quality Assurance Measures in Colorectal Cancer Survivorship Care Plans. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
2
|
Hanna TP, Baetz T, Xu J, Miao Q, Earle CC, Peng Y, Booth CM, Petrella TM, McKay DR, Nguyen P, Langley H, Eisenhauer E. Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuation. ACTA ACUST UNITED AC 2017; 24:e503-e512. [PMID: 29270059 DOI: 10.3747/co.24.3685] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background Although high-dose interferon (hd-ifn) is the sole approved adjuvant systemic treatment for melanoma in many jurisdictions, it is toxic. We sought to assess the population-level effects of hd-ifn toxicity, particularly neuropsychiatric toxicity, hypothesizing that such toxicity would have the greatest effect on mental health services use in advanced resected melanoma. Methods This retrospective population-based registry study considered all melanoma patients receiving adjuvant hd-ifn in Ontario during 2008-2012. Toxicity was investigated through health services use compatible with hd-ifn toxicity (for example, mental health physician billings). Using stage data reported from cancer centres about a subset of patients (stages iib-iiic), a propensity-matched analysis compared such service use in patients who did and did not receive hd-ifn. Associations between early hd-ifn discontinuation and health services use were examined. Results Of 718 melanoma patients who received hd-ifn, 12% were 65 years of age and older, and 83% had few or no comorbidities. One third of the patients experienced 1 or more toxicity-associated health care utilization events within 1 year of starting hd-ifn. Of 420 utilization events, 364 (87%) were mental health-related, with 54% being family practitioner visits, and 39% being psychiatrist visits. In the propensity-matched analysis, patients receiving hd-ifn were more likely than untreated matched controls to use a mental health service (p = 0.01), with 42% of the control group and 51% of the hd-ifn group using a mental health service in the period spanning the 12 months before to the 24 months after diagnosis. In the multivariable analysis, early drug discontinuation was more likely in the presence of pre-existing mental health issues (odds ratio: 2.0; 95% confidence limits: 1.1, 3.4). Conclusions Stage iib-iiic melanoma patients carry a substantial burden of mental health services use whether or not receiving hd-ifn, highlighting an important survivorship issue for these patients. High-dose interferon is associated with more use of mental health services, and pre-treatment use of mental health services is associated with treatment discontinuation. That association should be kept in mind when hd-ifn is being considered.
Collapse
Affiliation(s)
- T P Hanna
- Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston.,Department of Oncology, Queen's University, Kingston.,Institute for Clinical Evaluative Sciences, Queen's University, Kingston
| | - T Baetz
- Department of Oncology, Queen's University, Kingston
| | - J Xu
- Institute for Clinical Evaluative Sciences, Queen's University, Kingston.,Johnson and Johnson, Raritan, NJ, U.S.A
| | - Q Miao
- Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston.,Institute for Clinical Evaluative Sciences, Queen's University, Kingston
| | - C C Earle
- Faculty of Medicine, University of Toronto, Toronto.,Institute for Clinical Evaluative Sciences, Toronto
| | - Y Peng
- Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston.,Department of Mathematics and Statistics, Queen's University, Kingston
| | - C M Booth
- Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston.,Department of Oncology, Queen's University, Kingston.,Institute for Clinical Evaluative Sciences, Queen's University, Kingston
| | - T M Petrella
- Faculty of Medicine, University of Toronto, Toronto
| | - D R McKay
- Department of Surgery, Queen's University, Kingston; and
| | - P Nguyen
- Institute for Clinical Evaluative Sciences, Queen's University, Kingston
| | - H Langley
- South East Regional Cancer Program, Kingston General Hospital, Kingston, ON
| | - E Eisenhauer
- Department of Oncology, Queen's University, Kingston
| |
Collapse
|
3
|
Baker-Ward L, Quinonez R, Milano M, Lee S, Langley H, Brumley B, Ornstein PA. Predicting Children's Recall of a Dental Procedure: Contributions of Stress, Preparation, and Dental History. Appl Cognit Psychol 2015. [DOI: 10.1002/acp.3152] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Lynne Baker-Ward
- Department of Psychology; North Carolina State University; Raleigh USA
| | - Rocio Quinonez
- Department of Pediatric Dentistry, School of Dentistry; University of North Carolina at Chapel Hill; Chapel Hill USA
| | - Michael Milano
- Department of Pediatric Dentistry, School of Dentistry; University of North Carolina at Chapel Hill; Chapel Hill USA
| | - Seungjin Lee
- Department of Psychology; University of North Carolina at Chapel Hill; Chapel Hill USA
| | - Hillary Langley
- Department of Psychology; University of North Carolina at Chapel Hill; Chapel Hill USA
| | - Benjamin Brumley
- Department of Psychology; University of North Carolina at Chapel Hill; Chapel Hill USA
| | - Peter A. Ornstein
- Department of Psychology; University of North Carolina at Chapel Hill; Chapel Hill USA
| |
Collapse
|